Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1351416
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1351416
Intravenous Solutions Market, By Type, By Nutrients, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 307 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Intravenous Solutions Market size was valued at USD 11,910.11 Million in 2022, expanding at a CAGR of 8.11% from 2023 to 2030.
Intravenous infusion solutions, commonly referred to as IV infusions, are sterile liquid formulations administered directly into a patient's bloodstream through a needle or catheter. These specialized solutions are meticulously crafted to provide essential hydration, replenish vital electrolytes, and facilitate the delivery of medications or essential nutrients when a patient cannot ingest them orally.
Within the realm of healthcare, IV infusions play a pivotal role across various medical settings, encompassing hospitals, medical clinics, and emergency care units. Their significance lies in their ability to uphold and regulate proper fluid balance, support crucial physiological processes, and ensure the efficient dispensation of therapeutic compounds and nutrients.
Intravenous Solutions Market - Market Dynamics:
- Increasing incidence of diseases like neurological conditions, gastrointestinal disorders, and cancer
- The robust expansion of the Intravenous Solutions market can be attributed to the surging prevalence of various medical conditions, including gastrointestinal disorders, neurological ailments, and cancer. These conditions often necessitate the use of intravenous therapy for effective medication administration and hydration. Consequently, there has been a notable escalation in the demand for intravenous solutions, which serve as a crucial lifeline for patients. This heightened demand not only improves patient care but also fuels market growth, as healthcare professionals increasingly rely on these solutions to manage a wide spectrum of medical conditions.
- In line with global health data, the World Health Organization (WHO) reported that the global incidence of cancer exceeded 18.1 million cases in 2018, and this figure is projected to surge to 22.0 million by 2034. Furthermore, WHO statistics indicate that gastrointestinal diseases affect an estimated 60 to 70 million individuals in the United States. This prevalence underscores the growing need for parenteral nutritional solutions, encompassing glucose, phospholipids, glutamine, and amino acids, to address the healthcare requirements of patients.
Intravenous Solutions Market - Key Insights:
- According to insights provided by our research analysts, the global Intravenous Solutions market is anticipated to experience robust annual growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 7.9% during the forecast period spanning from 2023 to 2030.
- This industry's growth trajectory is underpinned by significant factors, primarily the escalating prevalence of various medical conditions such as neurological disorders, gastrointestinal ailments, and cancer.
- In terms of product categorization, the segment dedicated to total parenteral nutrition emerged as the leading contributor to market share for the year 2022.
- Furthermore, when considering nutrient segmentation, the single-dose amino acid category demonstrated its prominence in 2022.
- Geographically, North America emerged as the primary revenue-generating region for the market in the year 2022.
Intravenous Solutions Market- Segmentation Analysis:
- The worldwide Intravenous Solutions Market exhibits segmentation across three key dimensions: Type, Nutrient, and Geographic Region.
- In terms of Type classification, the market can be categorized into Total Parenteral Nutrition and Peripheral Parenteral Nutrition. Total Parenteral Nutrition involves the direct delivery of nourishing fluids into the bloodstream, bypassing the digestive system. The administration of these solutions is typically customized based on factors such as an individual's weight, age, height, and specific medical condition. These solutions find extensive use in the management of gastrointestinal disorders, treatment of burn injuries, addressing bowel syndromes, supporting patients undergoing chemotherapy, and facilitating post-surgical recovery.
Intravenous Solutions Market- Competitive Landscape:
Businesses employ a diverse array of strategies to bring their products to market, leveraging multiple channels like corporate websites, e-commerce platforms, retail partners, distributors, and direct-to-consumer approaches. Competition among product manufacturers centers on various factors encompassing pricing, performance, manufacturing processes, technological advancements, brand reputation, and product availability. To fortify their market presence and broaden their share, companies employ a range of tactics. These include the introduction of new products, the expansion of distribution networks, significant investments in research and development, and engaging in mergers and acquisitions.
For example, in February 2022, B. Braun Medical secured approval from the US Food and Drug Administration to initiate operations at their newly established IV saline solution production facility in Daytona Beach, Florida. In a separate instance from September 2021, B. Braun Medical Inc. unveiled CARESAFE IV Administration Sets, featuring an optional AirStop component, enhancing their product portfolio.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INTRAVENOUS SOLUTIONS MARKET KEY PLAYERS
- Vifor Pharma Group
- Vetter Pharma-Fertigung GmbH & Co. KG
- Terumo Corporation
- Smiths Medical (a division of Smiths Group plc)
- Sippex Pharmaceuticals Pvt. Ltd.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical Co., Ltd.
- JW Pharmaceutical Corporation
- ICU Medical, Inc.
- Hospira (now part of Pfizer Inc.)
- Grifols S.A.
- Fresenius SE & Co. KGaA
- Baxter International Inc.
- B. Braun Melsungen AG
- Amanta Healthcare Ltd.
GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY TYPE
- Total Parenteral Nutrition
- Peripheral Parenteral Nutrition
GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY NUTRIENT
- Single-Dose Amino Acid Solutions
- Carbohydrates
- Parenteral Lipid Emulsion
- Vitamins & Minerals
- Others
GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1664
Table of Contents
1. Intravenous Solutions Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Intravenous Solutions Market Snippet by Type
- 2.1.2. Intravenous Solutions Market Snippet by Nutrient
- 2.1.3. Intravenous Solutions Market Snippet by Country
- 2.1.4. Intravenous Solutions Market Snippet by Region
- 2.2. Competitive Insights
3. Intravenous Solutions Key Market Trends
- 3.1. Intravenous Solutions Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Intravenous Solutions Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Intravenous Solutions Market Opportunities
- 3.4. Intravenous Solutions Market Future Trends
4. Intravenous Solutions Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Intravenous Solutions Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Intravenous Solutions Market Landscape
- 6.1. Intravenous Solutions Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Intravenous Solutions Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
- 7.1.2. Total Parenteral Nutrition
- 7.1.3. Peripheral Parenteral Nutrition
8. Intravenous Solutions Market - By Nutrient
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Nutrient, 2022 & 2030 (%)
- 8.1.2. Single-Dose Amino Acid Solutions
- 8.1.3. Carbohydrates
- 8.1.4. Parenteral Lipid Emulsion
- 8.1.5. Vitamins & Minerals
- 8.1.6. Others
9. Intravenous Solutions Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Intravenous Solutions Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Intravenous Solutions Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Intravenous Solutions Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Intravenous Solutions Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Intravenous Solutions Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Intravenous Solutions Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Vifor Pharma Group
- 10.2.2. Vetter Pharma-Fertigung GmbH & Co. KG
- 10.2.3. Terumo Corporation
- 10.2.4. Smiths Medical (a division of Smiths Group plc)
- 10.2.5. Sippex Pharmaceuticals Pvt. Ltd.
- 10.2.6. Sichuan Kelun Pharmaceutical Co., Ltd.
- 10.2.7. Otsuka Pharmaceutical Co., Ltd.
- 10.2.8. JW Pharmaceutical Corporation
- 10.2.9. ICU Medical, Inc.
- 10.2.10. Hospira (now part of Pfizer Inc.)
- 10.2.11. Grifols S.A.
- 10.2.12. Fresenius SE & Co. KGaA
- 10.2.13. Baxter International Inc.
- 10.2.14. B. Braun Melsungen AG
- 10.2.15. Amanta Healthcare Ltd.
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
Product Code: ANV1664
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Intravenous Solutions Market: Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Intravenous Solutions Market, by Type 2018-2030 (USD Million)
- TABLE Intravenous Solutions Market: Nutrient Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Nutrient
- TABLE Global Intravenous Solutions Market, by Nutrient 2018-2030 (USD Million)
- TABLE Intravenous Solutions Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Intravenous Solutions Market, by Region 2018-2030 (USD Million)
- TABLE North America Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
- TABLE North America Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
- TABLE North America Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
- TABLE Europe Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
- TABLE Europe Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
- TABLE Asia Pacific Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
- TABLE Latin America Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
- TABLE Latin America Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
- TABLE Middle East and Africa Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.